Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

NDA submission for premature ejaculation treatment dapoxetine hydrochloride

Dec. 30, 2004

FDA approves Enablex for overactive bladder

Dec. 27, 2004

Improved PDE5 inhibitors selected for clinical studies on erectile dysfunction

Dec. 16, 2004

Recordati to develop silodosin for BPH in Europe

Dec. 15, 2004

Novel PDE5 inhibitor from Fujisawa

Dec. 13, 2004

Researchers at Dynogen describe a new treatment for urinary tract disorders

Dec. 7, 2004

Conivaptan increases serum sodium levels in patients with hyponatremia

Dec. 3, 2004

Approvable letter for hyponatremia drug YM-087

Dec. 3, 2004

AVE-7688 provides renal protection in diabetes model

Nov. 29, 2004

Vesicare approved by FDA

Nov. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...